Coartem tablets 24S
Ended Awarded Last action
- Contract number
- SPE2DR26FANM8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,562
Award facts
- Contract value 100% obligated
- $1,562.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,562.33 to AmerisourceBergen Drug Corp for Coartem Tablets 24S, a pharmaceutical product used in malaria treatment. The contract is non-competitive and employs firm fixed-price pricing, with a completion date of January 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company operates as a subsidiary of Cencora, Inc., which does business as AmerisourceBergen.
This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical commodities. The contract supports critical healthcare delivery to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. No set-aside designation applies to this award, reflecting AmerisourceBergen's capability to compete on a full and open basis for federal pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FANM8?
SPE2DR26FANM8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FANM8 worth?
The government has obligated $1,562 on SPE2DR26FANM8.
Is contract SPE2DR26FANM8 an order under another contract?
Yes. SPE2DR26FANM8 is a delivery order under SPE2DR25D6905, an indefinite delivery contract.
Was contract SPE2DR26FANM8 competed?
The extent of competition for SPE2DR26FANM8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award